ATS 2019 Virtual Final Program

CLINICAL YEAR IN REVIEW CME Credits Available: 2 MOC Points Available: 2 B1 CLINICAL YEAR IN REVIEW 2 : New! The Clinical Year in Review Bibliography is only available via the conference website http://conference.thoracic.org/go/cyir or mobile app. Attendees wishing to access the bibliography should bring a smart phone, tablet or laptop to the session. 9:15 a.m. - 11:15 a.m. KBHCCD Hall A (Level 2) Target Audience Providers including physicians, nurses, respiratory therapists, nurse practitioners, physician assistants; trainees including residents and fellows; clinical researchers Objectives At the conclusion of this session, the participant will be able to: • apply new clinical research knowledge to clinical practice; • learn new findings about key conditions in pulmonary, critical care and sleep; • have new strategies to manage the care of common conditions in pulmonary, critical care, and sleep The annual Clinical Year in Review symposia provides concise summaries of the most impactful clinical research publications related to specific clinical topics. Speakers are asked to conduct a literature review of the prior year’s scientific publications and develop a written summary of the top 20 articles and highlight 5 of the most important and influential publications on their topic in written format and during their talks at the International Conference Clinical Year in Review sessions. Chairing: V.E. Ortega, MD, PhD, ATSF, Winston Salem, NC J.S. Lee, MD, Aurora, CO P.A. Kritek, MD, EdM, Seattle, WA 9:14 Sarcoidosis J.C. Grutters, MD, Nieuwegein , Netherlands 9:44 Mycobacterial Infections D.J. Horne, MD, MPH, Seattle, WA 10:13 Asthma N. Lugogo, MD, Ann Arbor, MI 10:42 ARDS C.T.L. Hough, Seattle, WA 11:11 MOC Questions This session and the International Conference are supported by educational grants from Genentech, Inc., Insmed Incorporated, Mallinckrodt Pharmaceuticals, Novartis Pharmaceuticals Corporation, Sanofi Genzyme and Regeneron Pharmaceuticals. All CME sessions have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) and are free of the control of commercial interests. CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE CME Credits Available: 2 B2 ENDOBRONCHIAL VALVE TREATMENT IN PATIENTS WITH ADVANCED EMPHYSEMA: IT’S TIME HAS COME Assemblies on Clinical Problems; Nursing; Pulmonary Rehabilitation; Respiratory Structure and Function 9:15 a.m. - 11:15 a.m. KBHCCD Ballroom C One-Two (Level 2) Target Audience Clinicians and researchers who are involved with the care and research of patients with COPD who have emphysema Objectives At the conclusion of this session, the participant will be able to: • understand the pathophysiology and its consequences of severe hyperinflation on morbidity and mortality in patients with severe emphysema; • gain understanding of the principles of endobronchial valve placement, proper selection of patient candidates, and performance of procedure; • understand the adverse events that can result from endobronchial valve treatment and how to proactively mitigate against those complications. Multiple studies have been recently reported on the utility of endobronchial valve treatment in patients with heterogeneous and homogeneous disease to improve outcomes in patients with advanced emphysema and severe hyperinflation. This session will focus on these recent studies and provide the audience with information regarding patient selection, placement of endobronchial valve therapy, expected short and long-term outcomes as well as management of adverse events. Leading international investigators and practitioners with extensive experience in endobronchial valve placement will present at the session. Chairing: G.J. Criner, MD, ATSF, Philadelphia, PA D. Gompelmann, MD, Heidelberg, Germany F.J. Herth, DrMed, Heidelberg, Germany 9:15 Introduction G.J. Criner, MD, ATSF, Philadelphia, PA 9:16 Consequences of Severe Hyperinflation in Patients with Advanced Emphysema B.R. Celli, MD, Boston, MA 9:31 Lessons Learned from Lung Reduction Surgery W. Weder, MD, Zurich, Switzerland 9:46 Selection of Patients for Endobronchial Valve Therapy F.J. Herth, DrMed, Heidelberg, Germany 10:01 Outcomes of Endobronchial Valve Therapy in Patients with Heterogenous Emphysema G.J. Criner, MD, ATSF, Philadelphia, PA 10:15 Outcomes of Endobronchial Valve Therapy in Patients with Advanced Homogeneous Emphysema A. Valipour, MD, Vienna, Austria ATS 2019 • Dallas, TX MONDAY • MAY 20 123 MONDAY MORNING